Medigene AG MDGEF:OTCPK

RT Quote | Exchange | USD
Last | 02/25/21 EST
4.85UNCH (UNCH)
52 week range
3.80 - 6.68

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.85
  • 52 Week High6.68
  • 52 Week High Date07/22/20
  • 52 Week Low3.80
  • 52 Week Low Date03/20/20
  • Market Cap113.88M
  • Shares Out24.56M
  • 10 Day Average Volume200
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • 1 Year % Change-6.91

RATIOS/PROFITABILITY

  • EPS (TTM)-0.82
  • P/E (TTM)-5.93
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/28/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Medigene AG News

There is no recent news for this security.

Latest MDGEF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor...
Axel-Sven Malkomes
Chief Financial Officer
Address
Lochhamer Strasse 11
Planegg
82152
Germany